Icotrokinra vs KPV
Overview
Icotrokinra is primarily a immune support peptide, while KPV is used for pain management.
This page compares Icotrokinra and KPV across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Icotrokinra | KPV | |
|---|---|---|
| Category | Immune Support | Pain Management |
| Regulatory status (US) | FDA approved | Compounding (Rx) — Apr 2026 |
| Typical dosage | — | 500-1000 mcg |
| Frequency | — | daily |
| Reported benefits | — | Inflammation reduction, pain relief, gut-related pain support |
| Reported side effects | — | Very well-tolerated |
Key differences
Primary use. Icotrokinra is categorised under Immune Support, while KPV falls under Pain Management. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Icotrokinra: FDA-approved. KPV: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Typical dosing for Icotrokinra is not catalogued. KPV is typically dosed at 500-1000 mcg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Icotrokinra and KPV has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Icotrokinra and KPV?
- Icotrokinra is primarily a immune support peptide, while KPV is used for pain management. Icotrokinra is FDA-approved for one or more indications, whereas KPV is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Icotrokinra used for?
- Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.
- What is KPV used for?
- Anti-inflammatory pain relief.
- Can you take Icotrokinra and KPV together?
- Some users combine peptides within a single protocol, but stacking Icotrokinra and KPV has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Icotrokinra or KPV FDA-approved?
- Icotrokinra is FDA-approved for one or more indications. KPV is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Icotrokinra — full monograph: mechanism, research, dosing & references
- KPV — full monograph: mechanism, research, dosing & references